Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,382,608
  • Shares Outstanding, K 70,396
  • Annual Sales, $ 2,708 M
  • Annual Income, $ 247,100 K
  • EBIT $ 474 M
  • EBITDA $ 564 M
  • 60-Month Beta 1.47
  • Price/Sales 5.38
  • Price/Cash Flow 32.74
  • Price/Book 9.61

Options Overview Details

View History
  • Implied Volatility 47.92% (-1.36%)
  • Historical Volatility 33.39%
  • IV Percentile 78%
  • IV Rank 67.40%
  • IV High 60.02% on 04/10/25
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 13) 12.37 (6.05%)
  • Put/Call Vol Ratio 1.44
  • Today's Volume 22
  • Volume Avg (30-Day) 125
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 5,928
  • Open Int (30-Day) 6,605
  • Expected Range 191.94 to 216.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.14
  • Number of Estimates 8
  • High Estimate $1.29
  • Low Estimate $0.97
  • Prior Year $1.02
  • Growth Rate Est. (year over year) +11.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
202.44 +0.92%
on 04/02/26
247.60 -17.48%
on 03/04/26
-41.14 (-16.76%)
since 03/02/26
3-Month
202.44 +0.92%
on 04/02/26
299.80 -31.85%
on 01/07/26
-78.61 (-27.79%)
since 01/02/26
52-Week
202.44 +0.92%
on 04/02/26
354.88 -42.43%
on 11/20/25
-64.82 (-24.09%)
since 04/02/25

Most Recent Stories

More News
Insulet (PODD): 3 Reasons We Love This Stock

Insulet (PODD): 3 Reasons We Love This Stock

PODD : 204.31 (-1.32%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

NEW YORK , April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD). Such investors are advised...

PODD : 204.31 (-1.32%)
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky

Insulet Corp. Stock Falls After Voluntary Medical Device Correction Reveals Omnipod 5 Insulin-Leakage Defect Affecting Thousands of Pods

PODD : 204.31 (-1.32%)
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced...

PODD : 204.31 (-1.32%)
Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks

Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks

PODD : 204.31 (-1.32%)
Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today...

PODD : 204.31 (-1.32%)
ATTENTION Insulet Corporation (PODD) Investors: Possible Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Insulet Corporation ("Insulet Corporation") (NASDAQ: PODD) concerning...

PODD : 204.31 (-1.32%)
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or “the Company”)...

PODD : 204.31 (-1.32%)
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

OMCL : 34.15 (+0.62%)
PODD : 204.31 (-1.32%)
ALGN : 170.60 (-1.23%)
DXCM : 62.22 (-0.24%)
QDEL : 17.25 (+4.04%)
3 S&P 500 Stocks for Long-Term Investors

3 S&P 500 Stocks for Long-Term Investors

TJX : 161.29 (-0.46%)
CPAY : 293.34 (+1.30%)
PODD : 204.31 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 215.21
2nd Resistance Point 212.28
1st Resistance Point 208.30
Last Price 204.31
1st Support Level 201.38
2nd Support Level 198.45
3rd Support Level 194.47

See More

52-Week High 354.88
Fibonacci 61.8% 296.65
Fibonacci 50% 278.66
Fibonacci 38.2% 260.67
Last Price 204.31
52-Week Low 202.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.